This webinar will enable researchers to expand their knowledge of #ionchannels therapeutics, develop innovative strategies, and accelerate the development of new, more effective treatments for patients burdened by chronic trigeminal pain.
https://t.co/tp9TZz6MMK
#drugdiscovery
Registration is open for the Cambridge Ion Channel Forum 2025. Join us on 15th May for an exciting agenda featuring speakers from academia & industry.
๐๐๐ ๐ข๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง ๐ข๐ฌ ๐ง๐จ๐ฐ ๐จ๐ฉ๐๐ง: https://t.co/qiCD6uBbJZ
#ionchannels#electrophysiology#cicf25#drugdiscovery
Metrion's pioneering ion channel research has contributed to recognition in ๐๐ก๐ ๐๐ฎ๐ง๐๐๐ฒ ๐๐ข๐ฆ๐๐ฌ 100 ๐๐๐๐ก, celebrating Britainโs fastest-growing private tech companies. Read more: https://t.co/DVsu8b7VSa
#sundaytimes100#drugdiscovery#ionchannels#preclinical
I am super excited to have a front row seat as moderator for this pain webinar next month! @Goldpainlab and I were grad students together in the Neuroscience program at UCLA a few years back. I always enjoy hearing the latest from his great research team. #Pain
This webinar will enable researchers to expand their knowledge of #ionchannels therapeutics, develop innovative strategies, and accelerate the development of new, more effective treatments for patients burdened by chronic trigeminal pain.
https://t.co/9C5UKk2z3E
#drugdiscovery
Our panel of models, with increasing complexity and translational relevance, allow for more accurate prediction of human responses, reduce the risk of late-stage failures and provide a thorough understanding of drug mechanisms.
https://t.co/LdIaeZuIOT
#neuroscience#cns
Steve Jenkinson will be attending the American College of Toxicology Annual Meeting. Meet up with Steve to discuss how to reliably evaluate the proarrhythmic and cardiotoxic liabilities of your compounds. https://t.co/VPvcGiHAHk
#cardiacrisk#drugdiscovery#drugsafety
If you missed our poster 'Identification of venom fractions as TREK-1 modulators using Qube 384 automated patch clamp system' at Neuroscience let us know and we will send you a copy.
#drugdiscovery#ionchannels#neuroscience#cns
I am excited to have a front row seat at this Metrion Biosciences webinar as moderator! Be sure to register even if the time slot is not convenient...you can always watch later on demand (like Netflix!). #IonChannels
Next week we are proud to host a webinar which presents the patient perspective, electrophysiological research, and technologies used to develop a potential treatment for KCNC1-related disorders.
Register: https://t.co/2zh36aflrw
#drugdiscovery#CNS#raredisease#rarediseases
I'm excited to moderate this webinar. Even if the day/time is not convenient, be sure to register to learn more about this amazing #IonChannels case study and watch later on demand!
I always had a hunch that phosphatidic acid regulates ion channel function. This paper from @RohacsTibor and colleagues shows this nicely.
https://t.co/0Di7zd1PEj
#IonChannels
Cambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the specialist preclinical #CRO and a leader in #ionchannel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO).
https://t.co/TI1epvOLJZ
#newhire#CCO#drugdiscovery
Interesting open access review article on the role of #IonChannels and transporters in liver cancer. It seems that ion channels are indeed important targets in drug discovery for cancer treatments.
https://t.co/7wrkJdrFMt